Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 13;6(1):82.
doi: 10.1186/s13643-017-0472-0.

Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit

Affiliations

Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit

Jasmin Alloo et al. Syst Rev. .

Abstract

Background: Cochrane primarily aims to systematically review trials of effectiveness that are important to inform clinical decisions. Editorial groups support authors to achieve high-quality reviews and prioritise review proposals in their clinical domain that are submitted or elicited. Prioritising proposals requires two approaches, identifying (1) clinical practises for which the evidence of effectiveness is uncertain and (2) interventions in which there are trials of effectiveness (especially randomised controlled trials (RCTs)) not systematically reviewed. This study addresses this second approach for the Cochrane Acute Respiratory Infections Group (CARIG) in order to identify RCTs of acute respiratory infections that have not been systematically reviewed.

Methods: We exported, on the 9th of September 2014, and then compared the group's trials register of RCTs against a list of current Cochrane ARI (systematic) Reviews to identify gaps in topics (the same intervention and health condition) where completed trials have not been systematically reviewed. We assigned a principle intervention and health condition to each of 157 Cochrane reviews (CRs) and 5393 RCTs.

Results: A majority of topics had been systematically reviewed; however, a substantial number (2174 or 41%) of RCTs were not included in any review. The topic that had been systematically reviewed the most was antibiotic vs placebo for pneumonia with 11 CRs and 205 RCTs. The topic that was the subject of most RCTs was vaccination for influenza with 525 RCTs and 6 CRs. Also, 6 CRs had no RCTs ('empty reviews').

Conclusions: We identified many RCT topics that have not been systematically reviewed. They need to be addressed in a separate process to establish their priority to clinicians.

Keywords: Cochrane reviews; Research gaps; Research prioritisation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Graphical representation of CRs mapped to RCTs overview. Colours are used to identify the same interventions, for instance blue, as seen here, represents vaccination. In the live version, users can select the topic of interest by passing the mouse over it, which will expand the number of RCTs and CRs associated with that topic. The figure shows a static sub-section of the graph at http://crebp.github.io/CREBP-Disease-Treatment/
Fig. 2
Fig. 2
Graphical representation of Cochrane review mapped to RCTs (antibiotic vs antibiotic). This static screenshot shows the effects of a reader’s mouse over an intervention which is covered by a Cochrane review (here, antibiotic vs antibiotic): the right side of the figure expands to show the diseases for which antibiotic vs antibiotic has been studied
Fig. 3
Fig. 3
Graphical representation of Cochrane reviews mapped to RCTs (no CR, vaccination reminder). In this example, there is an intervention (vaccination reminders) with RCTs but no corresponding Cochrane review (a ‘review gap’). The RCT section has expanded to show the topics with available evidence that could be incorporated into a Cochrane review. The Cochrane review section is empty

Similar articles

References

    1. Cochrane: about us. http://www.cochrane.org/about-us. Accessed 22 Dec 2016.
    1. Cochrane Acute Respiratory Infections: about us. http://ari.cochrane.org/welcome. Accessed 22 Dec 2016.
    1. Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11(3):404–6. doi: 10.1513/AnnalsATS.201311-405PS. - DOI - PubMed
    1. Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N, Gill CJ. Systematic differences between Cochrane and non-Cochrane meta-analyses on the same topic: a matched pair analysis. PLoS One. 2015;10(12):e0144980. doi: 10.1371/journal.pone.0144980. - DOI - PMC - PubMed
    1. Ganann R, Ciliska D, Thomas H. Expediting systematic reviews: methods and implications of rapid reviews. Implement Sci. 2010;5:56. doi: 10.1186/1748-5908-5-56. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances